Global Addiction Conference Venice 2016

Events

Global Addiction Conference Venice 2016

10 February 2016

Global Addiction Association is looking to build year on year on the conference content. Addiction is a broad based topic and it is difficult to cover all aspects thoroughly, however, each year, we attempt to create some structure for the conference programme.

For 2016, in Europe, Global Addiction is looking to review the scientific and clinical aspects of Addiction, underlying mechanisms, clinical consequences, treatment options, epidemiology etc are all important in this regard. New treatments are emerging which could result in huge changes in the way people live their lives - taking a drug to reduce alcohol intake levels is a very different approach and we would like to review this option. New therapies are emerging for overdose, and some of the co-morbidities of addiction. Dual Diagnosis is becoming better recognised. In addition, the conference will review societal and policy initiatives which are shaping the way countries deal with addiction problems, and review the successes and failures at that level.

View the infographic below for a summary of topics covered by the conference:

The so-called 'novel’ addictions such as video game addictions, sex addiction, designer/club drugs, prescription drug addictions (eg. Opioid pain killers, sleeping pills, NSAIDS etc), gambling, cosmetic addictions (eg. amphetamine for weight loss, cosmetic surgery etc) continue to be of importance… and submissions on these topics will be well regarded for the conference, however as ever, any topic relating to addiction will be reviewed and can be included in the programme.

The committee is currently considering and accepting submissions on all these topics and creating the programme for the three day conference. To join the committee please email secretariat@globaladdiction.org with a short summary of your area of interest. Please be sure to state which conference you are interested in.

View the event website here.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.